Clinical Trial Update: Prospective Pilot Clinical Trial of Azithromycin Treatment In Respiratory Syncytial Virus (RSV)- Induced Respiratory Failure In Children [Phase 2]

View source ↗

Summary

Phase 2 pilot trial evaluating azithromycin for RSV-induced respiratory failure in children has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Failure in Children
• Respiratory Syncytial Virus Disease

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Respiratory Syncytial Virus | Phase 2 | Status: COMPLETED | Results posted: 2020-05-27